American Journal of Cardiovascular Drugs

Journal

Overview
Identity

Publication Venue For

Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. 15:275-285. 2015

Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]. 15:287. 2015

Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.. 12:233-243. 2012

Triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: The trinity randomized, double-blind, 12-week, parallel-group study. 12:233-243. 2012

Drug treatment of hyperuricemia to prevent cardiovascular outcomes: Are we there yet?. 12:1-6. 2012

Apolipoprotein E mimetics and cholesterol-lowering properties. 11:371-381. 2011

Fixed-dose combinations in the management of hypertension: Defining the place of angiotensin receptor antagonists and hydrochlorothiazide. 5:17-22. 2005

Strategies for minimizing hyperlipidemia after cardiac transplantation. 2:377-387. 2002

International Standard Serial Number (issn)

1175-3277

Electronic International Standard Serial Number (eissn)

1179-187X